Efficacy of BNG-1 to Treat Acute Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.
Also called NCT01675115
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 129 participants
- Sponsor
- Registry
-
NCT01675115
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01675115. Randomized; quadruple masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2014-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of BNG-1 to Treat Acute Ischemic Stroke
- Acronym
- BNG-1
- Condition
- Ischemic Stroke
- Intervention (Drug)
- BNG-1
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Chang Gung Memorial Hospital
Record details
- Record id
cardio:ct-nct01675115- Content hash
4884ec126f1781d1e493fa969fdeb18afe08d27375b16a6b4225c45531c4d29e